Skin Cancer Scientist Sees Ray of Hope: A Conversation with James Cleaver

By Jeff Miller on August 3, 2007

Photo of James Cleaver

James Cleaver

Much of what we know about how DNA repairs sun-damaged skin — or fails to do so — has arisen in the last few decades, thanks to scientists like UCSF's Jim Cleaver, PhD. Cleaver has a very long list of titles, including member of the National Academy of Sciences, but after more than 40 years at UCSF, he prefers to be known simply as a bench scientist who studies cancer.

And why not? It was at the bench that Cleaver first began to understand the underlying genetics of DNA repair by studying people with a rare disease known as xeroderma pigmentosum (XP). Lacking normal DNA repair mechanisms, those born with XP must avoid sunlight altogether. For them, light itself is malignant. And to survive what recessive genes have wrought, they must become, by necessity, children of the night.

Cleaver, who has become one of the world's leading experts on XP, began his career studying genetic changes among atomic bomb survivors. From his bench, he has been both witness and participant in the so-called war on cancer, and speaks with insight and hope about how a convergence of tools, techniques and discoveries has set the stage for a new advance against this dreaded disease.

Alternative content

Download MP3

 

Related Links

James E. Cleaver, PhD
UCSF Comprehensive Cancer Center
Two UCSF Scientists Elected to NAS
UCSF Daybreak, April 28, 1999
Xeroderma Pigmentosum
Wikipedia
Xeroderma Pigmentosum Society

 

Explore UCSF News

CLINICAL RESEARCH

New Lung Cancer Test Predicts Survival

In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.

BIOINFORMATICS

UCSF School of Medicine Leaders Explore Bioinformatics

Bioinformatics was the focus of this year’s daylong UCSF School of Medicine leadership retreat on January 20. Campus leaders examined the question of how to optimally develop, organize and integrate clinical-outcome data, research data, business intelligence, and population data.